Europe (WHO region) vs Ghana: New cases tested for RR-/MDR-TB
Europe (WHO region)
88.0%
in 2024
Ghana
100.0%
in 2024
Europe (WHO region) rank
3rd
Ghana rank
1st
New cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Ghana
How they compare
Ghana currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Ghana's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 1 time across 17 shared years of data; in 2005 it was Europe (WHO region) ahead.
Europe (WHO region) ranks 3rd and Ghana ranks 1st of 11 groups.
Across the 3 decades both report, Europe (WHO region) averaged higher in 2 and Ghana in 1.
Head to head by decade
| Decade | Europe (WHO region) | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.7% | 0.2% | 44.5% | Europe (WHO region) |
| 2010s | 86.7% | 40.6% | 46.1% | Europe (WHO region) |
| 2020s | 90.8% | 99.2% | 8.4% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Europe (WHO region) or Ghana?
- Ghana, at 100.0% against 88.0% in Europe (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Europe (WHO region) and Ghana?
- 12.0%, with Ghana ahead.
- How many years of comparable data are there for Europe (WHO region) and Ghana?
- 17 years are reported by both, from 2005 to 2024.
- How do Europe (WHO region) and Ghana rank globally for new cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 3rd and Ghana ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.